(Q34451762)

2 August 2017

1 reference

title

Diabetes mellitus and coronary heart disease. (English)

1 reference

2 August 2017

main subject

coronary artery disease

1 reference

Wilson PW

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Endocrinology and Metabolism Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

857-881

1 reference

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

An updated coronary risk profile. A statement for health professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The pathogenesis of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Non-insulin-dependent diabetes mellitus in minorities in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institut

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The relationship between metabolic control and vascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes and decline in heart disease mortality in US adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Timolol Treatment After Myocardial Infarction in Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Lipoprotein(a) and diabetes. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Management of dyslipidemia in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Coronary heart disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Decrease of Lipoprotein(a) With Improved Glycemic Control in IDDM Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Silent myocardial ischemia in patients with diabetes: who to screen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Role of diabetes in congestive heart failure: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Epidemiologic approach to the etiology of type I diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Atherosclerotic Vascular Disease and Its Risk Factors in Non-Insulin-Dependent Diabetic and Nondiabetic Subjects in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Detection of silent myocardial ischemia in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Influence of diabetes mellitus on the results of coronary bypass surgery. Follow-up of 212 diabetic patients ten to 15 years after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Left ventricular systolic function in middle-aged patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The clinical information value of the glycosylated hemoglobin assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Screening for asymptomatic coronary artery disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes-associated mortality in Native Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Calcium antagonists and the diabetic hypertensive patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Lens changes and the incidence of cardiovascular events among persons with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Smoking and other risk factors for coronary heart-disease in British civil servants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Insulin resistance is an important determinant of left ventricular mass in the obese

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Clinical and Operative Characteristics of Patients Randomized to Coronary Artery Bypass Surgery in the Bypass Angioplasty Revascularization Investigation (BARI)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Cardiomyopathy associated with noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin-dependent diabetes mellitus in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Comparative features of newly acquired left and right bundle branch block in the general population: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Impact of Obesity on Neuropathic Late Complications in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Myocardial infarction site and mortality in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes mellitus and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Epidemiology of diabetes mellitus in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetes mellitus as a risk factor for acute myocardial infarction in Asians and Europeans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970219-X

7 January 2021

10.1016/S0889-8529(05)70219-X

Identifiers

DOI

1 reference

2 August 2017

1 reference